Table 3.
SETD7 (ELISA) |
P value | SETED7 (IHC) |
P value | |||
---|---|---|---|---|---|---|
High (n = 78) |
Low (n = 37) |
High (n = 151) |
Low (n = 25) |
|||
Age (years) | 0.6444 | 0.1398 | ||||
≧65 | 58 | 26 | 85 | 18 | ||
<65 | 20 | 11 | 66 | 7 | ||
Sex | 0.2408 | 0.4748 | ||||
Male | 47 | 18 | 90 | 13 | ||
Female | 31 | 19 | 61 | 12 | ||
Histology | 0.7917 | 0.2862 | ||||
Undifferentiated | 12 | 5 | 32 | 3 | ||
Differentiated | 66 | 32 | 119 | 22 | ||
MSI | 0.0372 | 0.0277 | ||||
MSS/MSI-L | 56 | 33 | 116 | 24 | ||
MSI-H | 22 | 4 | 35 | 1 | ||
RASa | 0.1720 | 0.2652 | ||||
Wildtype | 28 | 6 | 25 | 9 | ||
Mutant | 21 | 10 | 32 | 6 | ||
Tumor sizeb | 0.0139 | 0.0451 | ||||
Tis, T1, T2 | 45 | 30 | 96 | 21 | ||
T3, T4 | 33 | 7 | 55 | 4 | ||
Lymph node metastasis | 0.9487 | 0.2893 | ||||
No | 48 | 23 | 101 | 14 | ||
Yes | 30 | 14 | 50 | 11 | ||
Distant metastasis | 0.4353 | 0.2725 | ||||
M0 | 62 | 27 | 123 | 18 | ||
M1 | 16 | 10 | 28 | 7 | ||
Stage | 0.8413 | 0.2499 | ||||
I | 19 | 7 | 40 | 6 | ||
II | 31 | 14 | 61 | 8 | ||
III | 12 | 6 | 19 | 7 | ||
IV | 16 | 10 | 31 | 4 |
Patients who received the RAS test were analyzed.
For ELISA and IHC analysis, the average tumor size was 43.1 mm and 45.5 mm respectively.